Atlas Trials

Qi deng

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qi deng

RecordFirmDate
Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia (NCT07538713)Qi deng2026-06-01
CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma (NCT07383233)Qi deng2026-06-01
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia (NCT07574073)Qi deng2026-06-01
Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders (NCT07365059)Qi deng2026-01-25
CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia (NCT07008872)Qi deng2025-06-01

Track Qi deng automatically

Every clearance here is in the API, with alerts when new ones post.